Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...

Ogunyooye, who leads the insurer’s brand and products in insurance, health, and investment in Nigeria, joined the company in ...

The makers of Tylenol have a new parent company. Kenvue, the acetaminophen manufacturer, announced that company Kimberly-Clark has acquired the consumer health brand. Kimberly-Clark is buying Kenvue ...

Siloed systems don’t just slow operations: they fail your customers, often at critical junctions in the customer experience. True integration is not a back-end fix, but a tool for understanding your ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...

The Chattanooga Area Food Bank, which activated its emergency response operations in mid-October, continues to lead a coordinated regional response as the suspension of November SNAP benefits ... more ...

Kimberly-Clark is making a big move with a nearly $50 billion acquisition. The North Texas company plans to acquire Kenvue ...

The deal will unite two giants in the over-the-counter health business, bringing together brands like Kleenex and Benadryl.

Bringing together Kenvue and Kimberly-Clark creates a uniquely positioned global leader in consumer health with a broader range of new growth opportunities ahead,” says ...

Kimberly-Clark will acquire Kenvue, the Johnson & Johnson spinoff, in a $48.7B cash and stock deal to create a global consumer health leader.